The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
SYLVESTER, R. J., van der MEIJDEN, A. P. M., & LAMM, D. L. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64273-5 · Cited by 1,312
TNM classification of malignant tumours
Cassoni, A. M. (1998) · Clinical Oncology · doi:10.1016/s0936-6555(98)80120-9 · Cited by 1,191
Histological Typing of Urinary Bladder Tumours
Mostofi, F. K., Davis, C. J., Sesterhenn, I. A., & Sobin, L. H. (1999) · Springer eBooks · doi:10.1007/978-3-642-59871-5 · Cited by 758
TNM classification of malignant tumours
Sobin, L. H. 1., Gospodarowicz, M. K. 1., & Wittekind, C. 1. (n.d.) · Cited by 676
Lamm, D. L., Blumenstein, B. A., Crawford, E. D., Montie, J. E., Scardino, P., Grossman, H. B., Stanisic, T. H., Smith, J. A., Sullivan, J., Sarosdy, M. F., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251703 · Cited by 605
BCG immunotherapy of bladder cancer: 20 years on
Alexandroff, A. B., Jackson, A. M., O'Donnell, M. A., & James, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07422-4 · Cited by 471
Methods to Improve Efficacy of Intravesical Mitomycin C: Results of a Randomized Phase III Trial
Au, J. L.-S., Badalament, R. A., Wientjes, M. G., Young, D. C., Warner, J. A., Venema, P. L., Pollifrone, D. L., Harbrecht, J. D., Chin, J. L., Lerner, S. P., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.8.597 · Cited by 308
Smith, J. A. J., Labasky, R. F., Cockett, A. T. �., Fracchia, J. A., Montie, J. E., & Rowland, R. G. (1999) · PubMed · Cited by 215
MARTÍNEZ-PIÑEIRO, J. A., MARTÍNEZ-PIÑEIRO, L., SOLSONA, E., RODRÍGUEZ, R. H., FERNÁNDEZ GÓMEZ, J. M., MARTÍN, M. G., MOLINA, J. R., COLLADO, A. G., FLORES, N., ISORNA, S., et al. (2005) · Journal of Urology · doi:10.1097/01.ju.0000173919.28835.aa · Cited by 201
Cited by
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Babjuk, M., Böhle, A., Burger, M., Capoun, O., Cohen, D., Compérat, E. M., Hernández, V., Kaasinen, E., Palou, J., Rouprêt, M., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.05.041 · Cited by 2,241
Babjuk, M., Burger, M., Capoun, O., Cohen, D., Compérat, E. M., Dominguez Escrig, J. L., Gontero, P., Liedberg, F., Masson-Lecomte, A., Mostafid, A. H., et al. (2022) · European Urology · doi:10.1016/j.eururo.2021.08.010 · Cited by 1,615
Kamat, A. M., Hahn, N. M., Efstathiou, J. A., Lerner, S. P., Malmström, P.-U., Choi, W., Guo, C. C., Lotan, Y., & Kassouf, W. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30512-8 · Cited by 1,421
Babjuk, M., Burger, M., Compérat, E. M., Gontero, P., Mostafid, A. H., Palou, J., van Rhijn, B. W. G., Rouprêt, M., Shariat, S. F., Sylvester, R., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.08.016 · Cited by 1,297
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Babjuk, M., Burger, M., Zigeuner, R., Shariat, S. F., van Rhijn, B. W. G., Compérat, E., Sylvester, R. J., Kaasinen, E., Böhle, A., Palou Redorta, J., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.06.003 · Cited by 1,174
Metadata
- Authors
- Di Stasi, S. M., Giannantoni, A., Giurioli, A., Valenti, M., Zampa, G., Storti, L., Attisani, F., De Carolis, A., Capelli, G., Vespasiani, G., & Stephen, R. L.
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 7
- Issue
- 1
- Pages
- 43-51
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W2111419267
- Cited by
- 282
- References
- 16
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s1470-2045(05)70472-1
- The paper
- Di Stasi, S. M., Giannantoni, A., Giurioli, A., Valenti, M., Zampa, G., Storti, L., Attisani, F., De Carolis, A., Capelli, G., Vespasiani, G., & Stephen, R. L. (2006). Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(05)70472-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.